Significant ETF Withdrawals Observed - VONV, UNH, CVX, WFC
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 09 2025
0mins
Source: NASDAQ.COM
VONV Share Price Analysis: VONV's 52-week low is $71.684 and high is $92.79, with the last trade recorded at $91.99, indicating a strong position near its high.
Understanding ETFs: Exchange traded funds (ETFs) function like stocks, where investors buy and sell "units" that can be created or destroyed based on demand.
Monitoring ETF Flows: Weekly tracking of shares outstanding helps identify ETFs with significant inflows (new units created) or outflows (units destroyed), impacting the underlying assets.
Disclaimer on Views: The opinions expressed in the article are those of the author and do not necessarily represent the views of Nasdaq, Inc.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy UNH?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on UNH
Wall Street analysts forecast UNH stock price to rise
19 Analyst Rating
16 Buy
3 Hold
0 Sell
Strong Buy
Current: 376.860
Low
330.00
Averages
397.82
High
444.00
Current: 376.860
Low
330.00
Averages
397.82
High
444.00
About UNH
UnitedHealth Group Incorporated is a healthcare and well-being company. Its segments include Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare, which includes UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement and UnitedHealthcare Community & State. Optum Health provides comprehensive and patient-centered care, addressing the physical, mental, and social well-being. Optum Health delivers primary, specialty and surgical care and helps patients and providers navigate and address complex, chronic and behavioral health needs. Optum Insight connects the healthcare system with services, analytics and platforms that make clinical, administrative and financial processes simpler and more efficient for all participants in the healthcare system. Optum Rx offers a range of pharmacy care services through retail pharmacies, through home delivery, specialty and community health pharmacies and the provision of in-home and community-based infusion services.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Abel's Portfolio Adjustments Post-Buffett at Berkshire Hathaway
- Portfolio Cleanup: Abel has conducted a 'spring cleaning' of Berkshire's portfolio by exiting several smaller positions, including UnitedHealth Group, indicating a focus on optimizing investments, although the long-term impact of these decisions remains uncertain.
- Exit from Notable Investments: In Q1 2026, Berkshire exited positions in well-known companies such as Amazon, Domino's Pizza, Mastercard, and Visa, reflecting Abel's search for new investment opportunities and possibly a response to market dynamics.
- New Investment Directions: Proceeds from these stock sales have been redirected into emerging investments like Delta Airlines and Macy's, while also significantly increasing stakes in Alphabet, showcasing confidence in future growth potential.
- Market Reaction Analysis: Despite UnitedHealth shares rising over 40% post-sale, market reactions to Abel's decisions are mixed, highlighting concerns over future earnings growth, particularly amid challenges facing the healthcare sector.
See More
Berkshire Exits Entire Stake in UnitedHealth Group
- Portfolio Adjustment: Berkshire Hathaway completely sold its 5 million shares of UnitedHealth Group in Q1 2026, indicating uncertainty about the healthcare stock's future performance, despite its over 40% rise since April.
- Core Investments Intact: While exiting UnitedHealth, Abel has not made significant changes to Berkshire's core investments, maintaining stakes in traditional quality assets like American Express and Coca-Cola, reflecting a commitment to long-term value.
- New Investment Directions: Proceeds from the sales likely flowed into new positions in Delta Airlines and Macy's, while also significantly increasing investments in Alphabet, indicating a focus on technology and consumer sectors.
- Future Growth Risks: UnitedHealth's management acknowledges that the company's turnaround is ongoing, and if future earnings growth fails to meet the 12.3% expectation, the stock could drop below $300 per share, reflecting market caution regarding its future performance.
See More
Goldman Sachs' Hedge Fund VIP List Includes Micron Technology
- Hedge Fund Favoritism: Micron Technology has made it to Goldman Sachs' coveted Hedge Fund VIP list, indicating strong interest from professional traders in its data and storage chips, reflecting optimistic market expectations for future growth.
- Outstanding Market Performance: The VIP basket has risen 10% year-to-date, outperforming the S&P 500's 9% gain, suggesting that hedge fund investment strategies are excelling in the current market environment, thereby boosting investor confidence in Micron.
- Stock Surge: Micron's shares soared 19% on Tuesday alone, pushing its market value past $1 trillion for the first time, primarily driven by insatiable AI demand for its memory chips, showcasing the company's competitiveness in emerging technologies.
- Analyst Optimism: UBS has tripled its price target on Micron to $1,625, believing that the market will start to assign a more 'normal' multiple to the stock, indicating that it is likely to continue rising as structural changes driven by AI unfold.
See More
Billionaires Reduce UnitedHealth Stock Holdings Amid Analyst Optimism
- Billionaire Sell-Off: Billionaires Chase Coleman and David Tepper reduced their stakes in UnitedHealth Group by 17% and 55% respectively in Q1 2026 according to 13F filings, despite analysts maintaining a bullish outlook, indicating a disconnect between market sentiment and investor actions.
- Rising Medical Costs: UnitedHealth faces challenges with rising medical costs that are squeezing profit margins, alongside increased uncertainty regarding Medicare Advantage rates, which may have influenced the billionaires' decision to sell, reflecting concerns about the company's future profitability.
- Analyst Optimism: Despite the sell-off, 22 out of 28 analysts surveyed by S&P Global rated UnitedHealth Group as a
See More
Billionaires Reduce Holdings in UnitedHealth Group Amid Mixed Sentiment
- Billionaire Sell-Off: Billionaires Chase Coleman and David Tepper reduced their stakes in UnitedHealth Group by approximately 17% and 55% respectively in Q1 2026, indicating a cautious stance despite analysts' overall bullish outlook on the stock.
- Cost Pressure Challenges: UnitedHealth faces rising medical costs that are squeezing profit margins, coupled with increased uncertainty regarding Medicare Advantage rates, which could impact future profitability.
- Analyst Optimism: Despite the sell-off, 22 out of 28 analysts still rated UnitedHealth Group as a 'buy' or 'strong buy', reflecting confidence in the company's improving business fundamentals and stock rebound.
- Strong Financial Performance: UnitedHealth's Q1 2026 earnings report exceeded analyst expectations, with a 90 basis point decline in the medical cost ratio to 83.9%, indicating positive progress in managing medical costs.
See More
Analysis of Berkshire Hathaway's Q1 Performance Under Greg Abel
- Small Position Cleanup: In Q1, Abel eliminated 16 small positions, including Visa and Amazon, none of which accounted for more than 1% of Berkshire's total portfolio, aiming to enhance focus and efficiency in the investment strategy to improve long-term performance.
- Decisive Exit from Losers: Berkshire sold off underperforming stocks like Pool Corp. and Domino's Pizza in Q1, which may have locked in losses, but Abel believes that timely exits are necessary to prevent dragging down overall investment performance amid uncertainty.
- Investment in Special Situations: Abel initiated new stakes in Delta Air Lines and Macy's during Q1, both facing systemic challenges, indicating a strategic willingness to invest in potentially undervalued companies that could yield returns in the future despite current difficulties.
- Increased Cash Reserves: As of the end of March, Berkshire's cash reserves reached $397 billion, suggesting that Abel may be waiting for more attractive investment opportunities while potentially shifting towards wholly-owned cash-generating businesses to reduce reliance on volatile stocks.
See More
Abel's Portfolio Adjustments Post-Buffett at Berkshire Hathaway
- Portfolio Cleanup: Abel has conducted a 'spring cleaning' of Berkshire's portfolio by exiting several smaller positions, including UnitedHealth Group, indicating a focus on optimizing investments, although the long-term impact of these decisions remains uncertain.
- Exit from Notable Investments: In Q1 2026, Berkshire exited positions in well-known companies such as Amazon, Domino's Pizza, Mastercard, and Visa, reflecting Abel's search for new investment opportunities and possibly a response to market dynamics.
- New Investment Directions: Proceeds from these stock sales have been redirected into emerging investments like Delta Airlines and Macy's, while also significantly increasing stakes in Alphabet, showcasing confidence in future growth potential.
- Market Reaction Analysis: Despite UnitedHealth shares rising over 40% post-sale, market reactions to Abel's decisions are mixed, highlighting concerns over future earnings growth, particularly amid challenges facing the healthcare sector.
See More
Berkshire Exits Entire Stake in UnitedHealth Group
- Portfolio Adjustment: Berkshire Hathaway completely sold its 5 million shares of UnitedHealth Group in Q1 2026, indicating uncertainty about the healthcare stock's future performance, despite its over 40% rise since April.
- Core Investments Intact: While exiting UnitedHealth, Abel has not made significant changes to Berkshire's core investments, maintaining stakes in traditional quality assets like American Express and Coca-Cola, reflecting a commitment to long-term value.
- New Investment Directions: Proceeds from the sales likely flowed into new positions in Delta Airlines and Macy's, while also significantly increasing investments in Alphabet, indicating a focus on technology and consumer sectors.
- Future Growth Risks: UnitedHealth's management acknowledges that the company's turnaround is ongoing, and if future earnings growth fails to meet the 12.3% expectation, the stock could drop below $300 per share, reflecting market caution regarding its future performance.
See More
Goldman Sachs' Hedge Fund VIP List Includes Micron Technology
- Hedge Fund Favoritism: Micron Technology has made it to Goldman Sachs' coveted Hedge Fund VIP list, indicating strong interest from professional traders in its data and storage chips, reflecting optimistic market expectations for future growth.
- Outstanding Market Performance: The VIP basket has risen 10% year-to-date, outperforming the S&P 500's 9% gain, suggesting that hedge fund investment strategies are excelling in the current market environment, thereby boosting investor confidence in Micron.
- Stock Surge: Micron's shares soared 19% on Tuesday alone, pushing its market value past $1 trillion for the first time, primarily driven by insatiable AI demand for its memory chips, showcasing the company's competitiveness in emerging technologies.
- Analyst Optimism: UBS has tripled its price target on Micron to $1,625, believing that the market will start to assign a more 'normal' multiple to the stock, indicating that it is likely to continue rising as structural changes driven by AI unfold.
See More
Billionaires Reduce UnitedHealth Stock Holdings Amid Analyst Optimism
- Billionaire Sell-Off: Billionaires Chase Coleman and David Tepper reduced their stakes in UnitedHealth Group by 17% and 55% respectively in Q1 2026 according to 13F filings, despite analysts maintaining a bullish outlook, indicating a disconnect between market sentiment and investor actions.
- Rising Medical Costs: UnitedHealth faces challenges with rising medical costs that are squeezing profit margins, alongside increased uncertainty regarding Medicare Advantage rates, which may have influenced the billionaires' decision to sell, reflecting concerns about the company's future profitability.
- Analyst Optimism: Despite the sell-off, 22 out of 28 analysts surveyed by S&P Global rated UnitedHealth Group as a
See More
Billionaires Reduce Holdings in UnitedHealth Group Amid Mixed Sentiment
- Billionaire Sell-Off: Billionaires Chase Coleman and David Tepper reduced their stakes in UnitedHealth Group by approximately 17% and 55% respectively in Q1 2026, indicating a cautious stance despite analysts' overall bullish outlook on the stock.
- Cost Pressure Challenges: UnitedHealth faces rising medical costs that are squeezing profit margins, coupled with increased uncertainty regarding Medicare Advantage rates, which could impact future profitability.
- Analyst Optimism: Despite the sell-off, 22 out of 28 analysts still rated UnitedHealth Group as a 'buy' or 'strong buy', reflecting confidence in the company's improving business fundamentals and stock rebound.
- Strong Financial Performance: UnitedHealth's Q1 2026 earnings report exceeded analyst expectations, with a 90 basis point decline in the medical cost ratio to 83.9%, indicating positive progress in managing medical costs.
See More
Analysis of Berkshire Hathaway's Q1 Performance Under Greg Abel
- Small Position Cleanup: In Q1, Abel eliminated 16 small positions, including Visa and Amazon, none of which accounted for more than 1% of Berkshire's total portfolio, aiming to enhance focus and efficiency in the investment strategy to improve long-term performance.
- Decisive Exit from Losers: Berkshire sold off underperforming stocks like Pool Corp. and Domino's Pizza in Q1, which may have locked in losses, but Abel believes that timely exits are necessary to prevent dragging down overall investment performance amid uncertainty.
- Investment in Special Situations: Abel initiated new stakes in Delta Air Lines and Macy's during Q1, both facing systemic challenges, indicating a strategic willingness to invest in potentially undervalued companies that could yield returns in the future despite current difficulties.
- Increased Cash Reserves: As of the end of March, Berkshire's cash reserves reached $397 billion, suggesting that Abel may be waiting for more attractive investment opportunities while potentially shifting towards wholly-owned cash-generating businesses to reduce reliance on volatile stocks.
See More
